Anthracycline
Showing 26 - 50 of 903
Pathogenesis of Anthracycline Cardiotoxicity
Not yet recruiting
- Childhood Cancer
- Cardiac MRI
- +2 more
-
Hartford, ConnecticutOlga Salazar
Jan 11, 2022
Cardiomyopathies, Chemo Effect, Diastolic Dysfunction Trial in Tehran (Bisoprolol, Placebo)
Completed
- Cardiomyopathies
- +3 more
- Bisoprolol
- Placebo
-
Tehran, Iran, Islamic Republic ofRasool Akram hospital
Dec 30, 2021
Leukemia, Cardiac Toxicity Trial in Pessac (Echographic analysis of myocardial deformation in 2D strain)
Completed
- Leukemia
- Cardiac Toxicity
- Echographic analysis of myocardial deformation in 2D strain
-
Pessac, FranceService de Cardiologie et Maladies Vasculaires, Hopital du Haut
Feb 8, 2022
Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer
Active, not recruiting
- Cancer
- Cardiotoxicity
- Exercise program
-
Hartford, Connecticut
- +1 more
Jan 11, 2022
Defining Late Onset Occult Asymptomatic Cardiotoxicity in
Active, not recruiting
- Cardiovascular Disease
- Cardiac MRI
-
Hartford, ConnecticutConnecticut Children's Medical Center
Jan 11, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
- (no location specified)
Jun 26, 2023
Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Epcoritamab
- Lenalidomide
- (no location specified)
Jan 20, 2023
Cancer, Heart Failure, Cardiotoxicity Trial in Toronto (Atorvastatin, Placebo oral tablet)
Active, not recruiting
- Cancer
- +2 more
- Atorvastatin
- Placebo oral tablet
-
Toronto, Ontario, CanadaToronto General Hospital
Feb 4, 2022
Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer
Completed
- Advanced Solid Tumors Amenable to Anthracycline Therapy
- Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
-
Münster, Germany
- +1 more
Apr 1, 2022
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Breast Cancer Trial (non invasive auricular vagal stimulation, usual medical treatment, sham stimulation)
Not yet recruiting
- Breast Cancer
- non invasive auricular vagal stimulation
- +2 more
- (no location specified)
May 17, 2022
Checkpoint Inhibitors in Triple Negative Breast
Recruiting
- Triple Negative Breast Cancer
- Whole Genome Sequencing
- +7 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Jun 20, 2023
Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)
Completed
- Breast Neoplasms
- Epirubicin
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Oct 26, 2022
Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)
Recruiting
- Anthracycline Related Cardiotoxicity in Breast Cancer
- sulforaphane
- Placebo Oral Tablet
-
Lubbock, TexasTexas Tech University Health Sciences Center
Jul 18, 2022
Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based
Not yet recruiting
- Breast Cancer
- Cancer of the Breast
- VENTANA MIB-1 Ki67 assay
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 18, 2023
Physical Exercise Intervention in Breast Cancer Patients at Risk
Recruiting
- Breast Cancer
-
Aberdeen, Aberdeenshire, United KingdomCardiovascular Research Facility
Sep 29, 2021
During Non-anthracycline Trastuzumab-based Therapy in Breast
Recruiting
- Breast Cancer
- Left Ventricular Ejection Fraction
-
Hartford, Connecticut
- +7 more
Mar 7, 2022
Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)
Withdrawn
- Breast Cancer
- Triple Negative Breast Cancer
- Durvalumab
- +3 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Aug 19, 2021
Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,
Recruiting
- Luminal B/HER2-negative Breast Cancer
- Dalpiciclib combined with aromatase inhibitors
- anthracycline-cyclophosphamide followed by taxane
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022
Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)
Recruiting
- Breast Cancer
- Non Hodgkin Lymphoma
-
Middlesbrough, Teesside, United KingdomSouth Tees Hospitals NHS FT
Oct 20, 2022
Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell
Completed
- Cardiomyopathy
- Heart Failure
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 11, 2022
Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)
Completed
- Breast Cancer
- anthracycline-based
- +3 more
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022
Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Fosaprepitant , Tropisetron and Olanzapine
- Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
-
Henan, Henan, China
- +1 more
Apr 11, 2022
Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)
Recruiting
- Metastatic Breast Cancer
- Ixabepilone Injection
-
Aalst, Belgium
- +11 more
Nov 28, 2022